Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers

Journal of Infectious Diseases

Volumn 187, Issue 7, 2003, Pages 1116-1125

  Furukawa, Yoshitaka ^a   Saito, Mineki ^a   Matsumoto, Wataru ^a   Usuku, Koichiro ^a   Tanaka, Yuetsu ^b   Izumo, Shuji ^a   Osame, Mitsuhiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TAX PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MONONUCLEAR CELL; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVIRUS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; VIRUS CARRIER; VIRUS PATHOGENESIS;

ADULT; CARRIER STATE; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAX; GENES, PX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; PROVIRUSES; VIRAL LOAD;

EID: 0037386158     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/368379     Document Type: Article

References (51)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77:7415-9.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79:2031-5.
3. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-10.
4. Osame M, Usuku K, Izumo S, et al. HTLV-I-associated myelopathy, a new clinical entity. Lancet 1986; 1:1031-2.
5. Akizuki S, Nakazato O, Higuchi Y, et al. Necropsy findings in HTLV-I-associated myelopathy. Lancet 1987; 1:156-7.
6. Yoshida M, Osame M, Kawai H, et al. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol 1989; 26:331-5.
7. Kira J, Koyanagi Y, Yamada T, et al. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol 1991; 29:194-201.
8. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998; 4:586-93.
9. Jeffery KJ, Siddiqui AA, Bunce M, et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 2000; 165:7278-84.
10. Vine AM, Witkover AD, Lloyd AL, et al. Polygenic control of HTLV-I infection outcome: HTLV-I-associated myelopathy (HAM) risk quantiffed by host genetic and viral factors. J Infect Dis 2002; 186:932-9.
11. Watanabe H, Nakamura T, Nagasato K, et al. Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell lymphotropic virus type I-associated myelopathy. Arch Neurol 1995; 52:276-80.
12. - cells from patients with HTLV-I-associated myelopathy. Tohoku J Exp Med 1996; 179:227-33.
13. Kuroda Y, Matsui M. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy. J Neuroimmunol 1993; 42:223-6.
14. Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1994; 53:72-7.
15. Hughes CC, Male DK, Lantos PL. Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-gamma, tumour necrosis factor, and interleukin-1. Immunology 1988; 64:677-81.
16. Sztein MB, Steeg PS, Johnson HM, Oppenheim JJ. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest 1984; 73:556-65.
17. Moore GR, Traugott U, Scheinberg LC, Raine CS. Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann Neurol 1989; 26:523-30.
18. + CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol 1997; 159:2018-25.
19. Sodroski JG, Rosen CA, Haseltine WA. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 1984; 225:381-5.
20. Siekevitz M, Feinberg MB, Holbrook N, Wong Staal F, Greene WC. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc Natl Acad Sci USA 1987; 84:5389-93.
21. Kim SJ, Kehrl JH, Burton J, et al. Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia. J Exp Med 1990; 172:121-9.
22. Lindholm PF, Reid RL, Brady JN. Extracellular Tax1 protein stimulates tumor necrosis factor-β and immunoglobulin kappa light chain expression in lymphoid cells. J Virol 1992; 66:1294-1302.
23. Mori N, Prager D. Transactivation of the interleukin-1α promoter by human T-cell leukemia virus. Leuk Lymphoma 1997; 26:421-33.
24. Mori N, Mukaida N, Ballard DW, Matsushima K, Yamamoto N. Human T-cell leukemia virus type I Tax transactivates human interleukin-8 gene through acting concurrently on AP-1 and nuclear factor-kappaB-like sites. Cancer Res 1998; 58:3993-4000.
25. Fujii M, Sassone Corsi P, Verma IM. c-fos promoter trans-activation by the taxi protein of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1988; 85:8526-30.
26. Oum JH, Han J, Myung H, Hleb M, Sharma S, Park J. Molecular mechanism of NFAT family proteins for differential regulation of the IL-2 and TNF-α promoters. Mol Cells 2002; 13:77-84.
27. Kiani A, Garcia-Cozar FJ, Habermann I, et al. Regulation of interferon-γ gene expression by nuclear factor of activated T cells. Blood 2001; 98:1480-8.
28. Rivera I, Harhaj EW, Sun SC. Involvement of NF-AT in type I human T-cell leukemia virus Tax-mediated Fas ligand promoter transactivation. J Biol Chem 1998; 273:22382-8.
29. Furukawa Y, Osame M, Kubota R, Tara M, Yoshida M. Human T-cell leukemia virus type-1 (HTLV-1) Tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. Blood 1995; 85:1865-70.
30. + T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 2002; 99:88-94.
31. Hanon E, Goon P, Taylor GP, et al. High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood 2001; 98:721-6.
32. Furukawa Y, Kubota R, Eiraku N, et al. Human T-cell lymphotropic virus type I (HTLV-I)-related clinical and laboratory findings in HTLV-I-infected blood donors. J Acquir Immune Defic Syndr 2003; 32:328-34.
33. Osame M. HTLV. In: Blattner WA, ed. Human retrovirology: review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. New York: Raven Press, 1990:191-7.
34. Lee B, Tanaka Y, Tozawa H. Monoclonal antibody defining Tax protein of human T-cell leukemia virus type-I. Tohoku J Exp Med 1989; 157:1-11.
35. Shimamoto Y, Miyahara M, Yamada H, Shibata K, Matsuzaki M, Ono K. Adult T-cell leukaemia/lymphoma with multiple integrations of human T-cell lymphotropic virus type I proviral DNA: differing clinical features are linked to varied proviral integration. Br J Haematol 1996; 92:632-8.
36. Furukawa Y, Fujisawa J, Osame M, et al. Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-1-associated myelopathy (HAM-TSP). Blood 1992; 80:1012-6.
37. + T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 2000; 13:657-64.
38. + T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 2001; 98:1858-61.
39. Asquith B, Bangham CRM. The role ofcytotoxic T lymphocytes in human T-cell lyrnphotropic virus type 1 infection. J Theor Biol 2000; 207:65-79.
40. Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelpathy/tropical spastic paraparesis. J Infect Dis 2000; 182:1343-9.
41. Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM. IL- 18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat Immunol 2001; 2:157-64.
42. + lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol 1998; 161:482-8.
43. Westby M, Marriott JB, Guckian M, Cookson S, Hay P, Dalgleish AG. Abnormal intracellular IL-2 and interferon-gamma (IFN-gamma) production as HIV-1-assocated markers of immune dysfunction. Clin Exp Immunol 1998; 111:257-63.
44. Umehara F, Izumo S, Nakagawa M, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1993; 52:424-30.
45. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170:2081-95.
46. Carvalho EM, Bacellar O, Porto AF, Braga S, Galvao-Castro B, Neva F. Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors. J Acquir Immune Defic Syndr 2001; 27:1-6.
47. Bream JH, Carrington M, O'Toole S, et al. Polymorphisms of the human IFNG gene noncoding regions. Immunogenetics 2000; 51:50-8.
48. Brown DA, Nelson FB, Reinherz EL, Diamond DJ. The human interferon-gamma gene contains an inducible promoter that can be transactivated by tax I and II. Eur J Immunol 1991; 21:1879-85.
49. Yoshimoto T, Takeda K, Tanaka T, et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 1998; 161:3400-7.
50. Harada H, Takahashi E, Itoh S, Harada K, Hori TA, Taniguchi T. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and [RF-2 genes: implications for a gene network in the interferon system. Mol Cell Biol 1994; 14:1500-9.
51. Sareneva T, Matikainen S, Kurimoto M, Julkunen I. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J Immunol 1998; 160:6032-8.